Dambkowski Carl
Chief Medical Officer
- Shares
- 5,500
- Price
- $134.17
- Value
- $737,935
APGE
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$737,935
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$173,958,266
7 distinct insiders
Highlighted alerts
2
85 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
APGE overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. This option represented the vested portion of the total right to purchase 47,758 shares of the Issuer's common stock, which vested in three approximately equal annual installments beginning on the first anniversary of the 7/13/2023 grant date. Under Mr. Harwin's arrangement with Fairmount Funds Management LLC (the "Adviser"), Mr. Harwin held the options reported herein for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). Mr. Harwin was obligated to turn over to the Adviser any net cash or stock received from the options for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaimed beneficial ownership of the option and underlying common stock. This option represented the right to purchase 10,370 shares of the Issuer's common stock, which vested on the one-year anniversary of the 6/5/2024 grant date.
Voluntary purchases and sales; administrative noise stays hidden.
Dambkowski Carl
Chief Medical Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Fairmount Funds Management LLC
Director
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Dambkowski Carl
Chief Medical Officer
Henderson Jane
Chief Financial Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Henderson Jane
Chief Financial Officer
Henderson Jane
Chief Financial Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
HENDERSON MICHAEL THOMAS
Chief Executive Officer
Henderson Jane
Chief Financial Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Shah Nimish P
Director
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
Dambkowski Carl
Chief Medical Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 05, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 5,500 | $134.17 | $737,935 | |
| Jul 08, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 20,000 | $133.63 | $2,672,600 | |
| Jul 01, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 5,500 | $132.74 | $730,070 | |
| Jun 22, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 26,400 | $132.60 | $3,500,640 | |
| Jun 22, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 80,000 | $132.54 | $10,603,200 | |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 614 | $86.89 | $53,350 | |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 2,305 | $86.27 | $198,852 | |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 1,577 | $85.19 | $134,345 | |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 1,080 | $84.18 | $90,914 | |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 7,654 | $82.78 | $633,598 | |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 6,770 | $82.21 | $556,562 | |
| Jun 03, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 5,500 | $78.71 | $432,905 | |
| May 13, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 1,341 | $82.58 | $110,740 | |
| May 13, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 18,659 | $82.05 | $1,530,971 | |
| May 06, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 1,800 | $84.60 | $152,280 | |
| May 06, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 3,700 | $83.92 | $310,504 | |
| May 01, 2026 | Henderson Jane Chief Financial Officer | Sale | 289 | $83.16 | $24,033 | |
| May 01, 2026 | Henderson Jane Chief Financial Officer | Sale | 900 | $82.60 | $74,340 | |
| May 01, 2026 | Henderson Jane Chief Financial Officer | Sale | 811 | $81.02 | $65,707 | |
| Apr 16, 2026 | Henderson Jane Chief Financial Officer | Sale | 2,000 | $90.00 | $180,000 | |
| Apr 08, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 200 | $85.00 | $17,000 | |
| Apr 08, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 2,000 | $83.26 | $166,520 | |
| Apr 08, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 17,800 | $82.48 | $1,468,144 | |
| Apr 01, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 100 | $85.89 | $8,589 | |
| Apr 01, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 2,702 | $85.33 | $230,562 | |
| Apr 01, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 2,698 | $84.31 | $227,468 | |
| Apr 01, 2026 | Henderson Jane Chief Financial Officer | Sale | 1,100 | $85.46 | $94,006 | |
| Apr 01, 2026 | Henderson Jane Chief Financial Officer | Sale | 900 | $84.46 | $76,014 | |
| Mar 25, 2026 | Henderson Jane Chief Financial Officer | Sale | 2,000 | $85.00 | $170,000 | |
| Mar 11, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 3,418 | $75.86 | $259,289 | |
| Mar 11, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 8,219 | $74.83 | $615,028 | |
| Mar 11, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 8,363 | $74.29 | $621,287 | |
| Mar 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 200 | $73.26 | $14,652 | |
| Mar 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 2,075 | $71.98 | $149,359 | |
| Mar 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 3,225 | $70.33 | $226,814 | |
| Mar 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 406 | $71.66 | $29,094 | |
| Mar 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 994 | $70.45 | $70,027 | |
| Mar 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 300 | $69.43 | $20,829 | |
| Mar 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 300 | $68.27 | $20,481 | |
| Feb 11, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 955 | $64.99 | $62,065 | |
| Feb 11, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 7,551 | $63.73 | $481,225 | |
| Feb 11, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 11,494 | $62.96 | $723,662 | |
| Feb 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 200 | $68.94 | $13,788 | |
| Feb 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 100 | $67.88 | $6,788 | |
| Feb 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 1,299 | $66.85 | $86,838 | |
| Feb 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 1,420 | $65.83 | $93,479 | |
| Feb 04, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 2,481 | $64.88 | $160,967 | |
| Feb 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 100 | $66.89 | $6,689 | |
| Feb 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 1,108 | $66.15 | $73,294 | |
| Feb 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 792 | $65.21 | $51,646 | |
| Jan 22, 2026 | Fairmount Funds Management LLC Director | Sale | 1,750,000 | $76.30 | $133,525,000 | |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 470 | $83.79 | $39,381 | |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 5,386 | $83.16 | $447,900 | |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 1,854 | $82.41 | $152,788 | |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 2,374 | $81.00 | $192,294 | |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 8,476 | $79.82 | $676,554 | |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 1,440 | $78.64 | $113,242 | |
| Jan 07, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 100 | $80.06 | $8,006 | |
| Jan 07, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 826 | $79.04 | $65,287 | |
| Jan 07, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 14,820 | $77.90 | $1,154,478 | |
| Jan 07, 2026 | Dambkowski Carl Chief Medical Officer | Sale | 2,954 | $77.13 | $227,842 | |
| Jan 06, 2026 | Henderson Jane Chief Financial Officer | Sale | 2,000 | $80.00 | $160,000 | |
| Jan 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 4,080 | $75.20 | $306,816 | |
| Jan 02, 2026 | Henderson Jane Chief Financial Officer | Sale | 1,920 | $74.13 | $142,330 | |
| Dec 19, 2025 | Henderson Jane Chief Financial Officer | Sale | 1,500 | $80.00 | $120,000 | |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 560 | $76.58 | $42,885 | |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 10,005 | $75.79 | $758,279 | |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 9,435 | $74.88 | $706,493 | |
| Dec 04, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 10,900 | $75.00 | $817,500 | |
| Dec 04, 2025 | Henderson Jane Chief Financial Officer | Sale | 1,500 | $75.00 | $112,500 | |
| Dec 04, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 40,000 | $75.01 | $3,000,400 | |
| Nov 25, 2025 | Henderson Jane Chief Financial Officer | Sale | 1,500 | $70.00 | $105,000 | |
| Nov 14, 2025 | Henderson Jane Chief Financial Officer | Sale | 2,000 | $65.00 | $130,000 | |
| Nov 13, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 100 | $64.52 | $6,452 | |
| Nov 13, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 1,786 | $63.89 | $114,108 | |
| Nov 13, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 14,774 | $63.14 | $932,830 | |
| Nov 13, 2025 | HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale | 3,340 | $61.93 | $206,846 | |
| Nov 11, 2025 | Henderson Jane Chief Financial Officer | Sale | 1,000 | $60.00 | $60,000 | |
| Nov 05, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 678 | $56.51 | $38,314 | |
| Nov 05, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 5,607 | $55.58 | $311,637 | |
| Nov 05, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 2,200 | $54.83 | $120,626 | |
| Nov 05, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 2,300 | $53.62 | $123,326 | |
| Oct 10, 2025 | Shah Nimish P Director | Purchase | 365,853 | $41.00 | $14,999,936 | |
| Oct 01, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 5,110 | $39.80 | $203,378 | |
| Sep 03, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 190 | $38.55 | $7,325 | |
| Sep 03, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 2,535 | $37.82 | $95,874 | |
| Aug 06, 2025 | Dambkowski Carl Chief Medical Officer | Sale | 2,725 | $37.78 | $102,951 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.